This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adachi, S. Articles by Akiyama, T. Search for Related Content PubMed PubMed Citation Articles by Adachi, S. Articles by Akiyama, T.

Role of a BCL9-Related ß-Catenin-Binding Protein, B9L, in Tumorigenesis Induced by Aberrant Activation of Wnt Signaling

¹ Laboratory of Molecular and Genetic Information, Institute for Molecular and Cellular Biosciences and ² Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; ³ Second Department of Surgery, Gunma University School of Medicine, Gunma, Japan; ⁴ OTSUKA GEN Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan; and ⁵ Department of Molecular Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Wnt signaling plays a crucial role in a number of developmental processes and in tumorigenesis. ß-Catenin is stabilized by Wnt signaling and associates with the TCF/LEF family of transcription factors, thereby activating transcription of Wnt target genes. Constitutive activation of ß-catenin-TCF–mediated transcription resulting from mutations in adenomatous polyposis coli (APC), ß-catenin, or Axin is believed to be a critical step in tumorigenesis among divergent types of cancers. Here we show that the transactivation potential of the ß-catenin-TCF complex is enhanced by its interaction with a BCL9-like protein, B9L, in addition to BCL9. We found that B9L is required for enhanced ß-catenin-TCF–mediated transcription in colorectal tumor cells and for ß-catenin–induced transformation of RK3E cells. Furthermore, expression of B9L was aberrantly elevated in about 43% of colorectal tumors, relative to the corresponding noncancerous tissues. These results suggest that B9L plays an important role in tumorigenesis induced by aberrant activation of Wnt signaling.

This article has been cited by other articles:

				M. Mani, D. E. Carrasco, Y. Zhang, K. Takada, M. E. Gatt, J. Dutta-Simmons, H. Ikeda, F. Diaz-Griffero, V. Pena-Cruz, M. Bertagnolli, et al. BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells Cancer Res., October 1, 2009; 69(19): 7577 - 7586. [Abstract] [Full Text] [PDF]

				C. Sustmann, H. Flach, H. Ebert, Q. Eastman, and R. Grosschedl Cell-Type-Specific Function of BCL9 Involves a Transcriptional Activation Domain That Synergizes with {beta}-Catenin Mol. Cell. Biol., May 15, 2008; 28(10): 3526 - 3537. [Abstract] [Full Text] [PDF]